Exact Mass: 479.1556
Exact Mass Matches: 479.1556
Found 500 metabolites which its exact mass value is equals to given mass value 479.1556
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Petunidin 3-glucoside
Acquisition and generation of the data is financially supported in part by CREST/JST.
(E)-1-(glutathion-S-yl)-N-hydroxy-2-(1H-indol-3-yl)ethan-1-imine
Trifluoperazine hydrochloride
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics
JNJ-38431055
Petunidin 3-galactoside
Pigment from whortleberry, blackberry, etc. Petunidin 3-galactoside is found in many foods, some of which are common grape, bilberry, black chokeberry, and sweet cherry. Petunidin 3-galactoside is found in american cranberry. Petunidin 3-galactoside is a pigment from whortleberry, blackberry, etc.
Petunidin 3-glucoside
Present in red wine. Petunidin 3-glucoside is found in many foods, some of which are common grape, gooseberry, highbush blueberry, and sweet cherry. Petunidin 3-glucoside is found in alcoholic beverages. Petunidin 3-glucoside is present in red wine.
4'-O-Methyldelphinidin 3-O-beta-D-glucoside
4-O-Methyldelphinidin 3-O-beta-D-glucoside is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
Avosentan
C28313 - Endothelin Receptor Antagonist Avosentan(Ro 67-0565; SPP-301) is a potent, selective endothelin receptor(ETA receptor) antagonist. IC50 value: Target: ETA receptor
4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone
3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester
Letaxaban
Petunidin 3-galactoside
2-(2-amino-O5-carbamoyl-L-erythro-2,3-dideoxy-pentonoylamino)-1-(5-fluoro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-beta-D-1,5-dideoxy-allofuranuronic acid|5-Fluoropolyoxin M
beta-D-fructofuranosyl-(2->1)-alpha-D-[2-O-L-hystidyl]glucopyranoside
LY-411575
D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators
Ala Cys Met Arg
Ala Cys Arg Met
Ala Cys Thr Trp
Ala Cys Trp Thr
Ala Met Cys Arg
Ala Met Met Gln
Ala Met Gln Met
Ala Met Arg Cys
Ala Gln Met Met
Ala Arg Cys Met
Ala Arg Met Cys
Ala Thr Cys Trp
Ala Thr Trp Cys
Ala Trp Cys Thr
Ala Trp Thr Cys
Cys Ala Met Arg
Cys Ala Arg Met
Cys Ala Thr Trp
Cys Ala Trp Thr
Cys Cys Arg Val
Cys Cys Val Arg
Cys Asp Asp Lys
Cys Asp Asp Gln
Cys Asp Glu Asn
Cys Asp Gly Trp
Cys Asp Lys Asp
Cys Asp Asn Glu
Cys Asp Gln Asp
Cys Asp Arg Ser
Cys Asp Ser Arg
Cys Asp Trp Gly
Cys Glu Asp Asn
Cys Glu Asn Asp
Cys Glu Gln Thr
Cys Glu Thr Gln
Cys Phe Asn Pro
Cys Phe Pro Asn
Cys Gly Asp Trp
Cys Gly Trp Asp
Cys Ile Met Asn
Cys Ile Asn Met
Cys Lys Asp Asp
Cys Leu Met Asn
Cys Leu Asn Met
Cys Met Ala Arg
Cys Met Ile Asn
Cys Met Leu Asn
Cys Met Asn Ile
Cys Met Asn Leu
Cys Met Gln Val
Cys Met Arg Ala
Cys Met Val Gln
Cys Asn Asp Glu
Cys Asn Glu Asp
Cys Asn Phe Pro
Cys Asn Ile Met
Cys Asn Leu Met
Cys Asn Met Ile
Cys Asn Met Leu
Cys Asn Pro Phe
Cys Pro Phe Asn
Cys Pro Asn Phe
Cys Gln Asp Asp
Cys Gln Glu Thr
Cys Gln Met Val
Cys Gln Thr Glu
Cys Gln Val Met
Cys Arg Ala Met
Cys Arg Asp Ser
Cys Arg Ser Asp
Cys Ser Asp Arg
Cys Ser Arg Asp
Cys Thr Ala Trp
Cys Thr Glu Gln
Cys Thr Gln Glu
Cys Thr Trp Ala
Cys Val Met Gln
Cys Val Gln Met
Cys Trp Ala Thr
Cys Trp Asp Gly
Cys Trp Gly Asp
Cys Trp Thr Ala
Asp Cys Asp Lys
Asp Cys Asp Gln
Asp Cys Glu Asn
Asp Cys Gly Trp
Asp Cys Lys Asp
Asp Cys Asn Glu
Asp Cys Gln Asp
Asp Cys Arg Ser
Asp Cys Ser Arg
Asp Cys Trp Gly
Asp Asp Cys Lys
Asp Asp Cys Gln
Asp Asp Lys Cys
Asp Asp Gln Cys
Asp Glu Cys Asn
Asp Glu Asn Cys
Asp Gly Cys Trp
Asp Gly Trp Cys
Asp Lys Cys Asp
Asp Lys Asp Cys
Asp Met Asn Thr
Asp Met Gln Ser
Asp Met Ser Gln
Asp Met Thr Asn
Asp Asn Cys Glu
Asp Asn Glu Cys
Asp Asn Met Thr
Asp Asn Thr Met
Asp Gln Cys Asp
Asp Gln Asp Cys
Asp Gln Met Ser
Asp Gln Ser Met
Asp Arg Cys Ser
Asp Arg Ser Cys
Asp Ser Cys Arg
Asp Ser Met Gln
Asp Ser Gln Met
Asp Ser Arg Cys
Asp Thr Met Asn
Asp Thr Asn Met
Asp Trp Cys Gly
Asp Trp Gly Cys
Glu Cys Asp Asn
Glu Cys Asn Asp
Glu Cys Gln Thr
Glu Cys Thr Gln
Glu Asp Cys Asn
Glu Asp Asn Cys
Glu Met Asn Ser
Glu Met Ser Asn
Glu Asn Cys Asp
Glu Asn Asp Cys
Glu Asn Met Ser
Glu Asn Ser Met
Glu Gln Cys Thr
Glu Gln Thr Cys
Glu Ser Met Asn
Glu Ser Asn Met
Glu Thr Cys Gln
Glu Thr Gln Cys
Phe Cys Asn Pro
Phe Cys Pro Asn
Phe Asn Cys Pro
Phe Asn Pro Cys
Phe Pro Cys Asn
Phe Pro Asn Cys
Gly Cys Asp Trp
Gly Cys Trp Asp
Gly Asp Cys Trp
Gly Asp Trp Cys
Gly Met Ser Trp
Gly Met Trp Ser
Gly Ser Met Trp
Gly Ser Trp Met
Gly Trp Cys Asp
Gly Trp Asp Cys
Gly Trp Met Ser
Gly Trp Ser Met
Ile Cys Met Asn
Ile Cys Asn Met
Ile Met Cys Asn
Ile Met Asn Cys
Ile Asn Cys Met
Ile Asn Met Cys
Lys Cys Asp Asp
Lys Asp Cys Asp
Lys Asp Asp Cys
Leu Cys Met Asn
Leu Cys Asn Met
Leu Met Cys Asn
Leu Met Asn Cys
Leu Asn Cys Met
Leu Asn Met Cys
Met Ala Met Gln
Met Ala Gln Met
Met Cys Ile Asn
Met Cys Leu Asn
Met Cys Asn Ile
Met Cys Asn Leu
Met Cys Gln Val
Met Cys Val Gln
Met Asp Asn Thr
Met Asp Gln Ser
Met Asp Ser Gln
Met Asp Thr Asn
Met Glu Asn Ser
Met Glu Ser Asn
Met Gly Ser Trp
Met Gly Trp Ser
Met Ile Cys Asn
Met Ile Asn Cys
Met Leu Cys Asn
Met Leu Asn Cys
Met Met Ala Gln
Met Met Gln Ala
Met Asn Cys Ile
Met Asn Cys Leu
Met Asn Asp Thr
Met Asn Glu Ser
Met Asn Ile Cys
Met Asn Leu Cys
Met Asn Ser Glu
Met Asn Thr Asp
Met Gln Ala Met
Met Gln Cys Val
Met Gln Asp Ser
Met Gln Met Ala
Met Gln Ser Asp
Met Gln Val Cys
Met Ser Asp Gln
Met Ser Glu Asn
Met Ser Gly Trp
Met Ser Asn Glu
Met Ser Gln Asp
Met Ser Trp Gly
Met Thr Asp Asn
Met Thr Asn Asp
Met Val Cys Gln
Met Val Gln Cys
Met Trp Gly Ser
Met Trp Ser Gly
Asn Cys Asp Glu
Asn Cys Glu Asp
Asn Cys Phe Pro
Asn Cys Ile Met
Asn Cys Leu Met
Asn Cys Met Ile
Asn Cys Met Leu
Asn Cys Pro Phe
Asn Asp Cys Glu
Asn Asp Glu Cys
Asn Asp Met Thr
Asn Asp Thr Met
Asn Glu Cys Asp
Asn Glu Asp Cys
Asn Glu Met Ser
Asn Glu Ser Met
Asn Phe Cys Pro
Asn Phe Pro Cys
Asn Ile Cys Met
Asn Ile Met Cys
Asn Leu Cys Met
Asn Leu Met Cys
Asn Met Cys Ile
Asn Met Cys Leu
Asn Met Asp Thr
Asn Met Glu Ser
Asn Met Ile Cys
Asn Met Leu Cys
Asn Met Ser Glu
Asn Met Thr Asp
Asn Pro Cys Phe
Asn Pro Phe Cys
Asn Ser Glu Met
Asn Ser Met Glu
Asn Thr Asp Met
Asn Thr Met Asp
Pro Cys Phe Asn
Pro Cys Asn Phe
Pro Phe Cys Asn
Pro Phe Asn Cys
Pro Asn Cys Phe
Pro Asn Phe Cys
Gln Ala Met Met
Gln Cys Asp Asp
Gln Cys Glu Thr
Gln Cys Met Val
Gln Cys Thr Glu
Gln Cys Val Met
Gln Asp Cys Asp
Gln Asp Asp Cys
Gln Asp Met Ser
Gln Asp Ser Met
Gln Glu Cys Thr
Gln Glu Thr Cys
Gln Met Ala Met
Gln Met Cys Val
Gln Met Asp Ser
Gln Met Met Ala
Gln Met Ser Asp
Gln Met Val Cys
Gln Ser Asp Met
Gln Ser Met Asp
Gln Thr Cys Glu
Gln Thr Glu Cys
Gln Val Cys Met
Gln Val Met Cys
Arg Cys Asp Ser
Arg Cys Ser Asp
Arg Asp Cys Ser
Arg Asp Ser Cys
Arg Ser Cys Asp
Arg Ser Asp Cys
Ser Cys Asp Arg
Ser Cys Arg Asp
Ser Asp Cys Arg
Ser Asp Met Gln
Ser Asp Gln Met
Ser Asp Arg Cys
Ser Glu Met Asn
Ser Glu Asn Met
Ser Gly Met Trp
Ser Gly Trp Met
Ser Met Asp Gln
Ser Met Glu Asn
Ser Met Gly Trp
Ser Met Asn Glu
Ser Met Gln Asp
Ser Met Trp Gly
Ser Asn Glu Met
Ser Asn Met Glu
Ser Gln Asp Met
Ser Gln Met Asp
Ser Arg Cys Asp
Ser Arg Asp Cys
Ser Trp Gly Met
Ser Trp Met Gly
Thr Ala Cys Trp
Thr Ala Trp Cys
Thr Cys Ala Trp
Thr Cys Glu Gln
Thr Cys Gln Glu
Thr Cys Trp Ala
Thr Asp Met Asn
Thr Asp Asn Met
Thr Glu Cys Gln
Thr Glu Gln Cys
Thr Met Asp Asn
Thr Met Asn Asp
Thr Asn Asp Met
Thr Asn Met Asp
Thr Gln Cys Glu
Thr Gln Glu Cys
Thr Trp Ala Cys
Thr Trp Cys Ala
Val Cys Met Gln
Val Cys Gln Met
Val Met Cys Gln
Val Met Gln Cys
Val Gln Cys Met
Val Gln Met Cys
Trp Ala Cys Thr
Trp Ala Thr Cys
Trp Cys Ala Thr
Trp Cys Asp Gly
Trp Cys Gly Asp
Trp Cys Thr Ala
Trp Asp Cys Gly
Trp Asp Gly Cys
Trp Gly Cys Asp
Trp Gly Asp Cys
Trp Gly Met Ser
Trp Gly Ser Met
Trp Met Gly Ser
Trp Met Ser Gly
Trp Ser Gly Met
Trp Ser Met Gly
Trp Thr Ala Cys
Trp Thr Cys Ala
4'-O-Methyldelphinidin 3-O-beta-D-glucoside
[N-[alpha-[2-(Dibutylglycinamido)phenyl]benzylidene]glycinato]nickel
4-ethynyl-3-[3-fluoro-4-[(2-methylimidazo[4,5-c]pyridin-1-yl)methyl]benzoyl]-N,N-dimethylindole-1-carboxamide
(S)-trans-N-3-{3-(2-aminocyclopropyl)phenoxy}-1-benzylcarbamoyl propylbenzamide hydrochloride
Pevonedistat Hydrochloride
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
MK-2206 2HCl
MK-2206 dihydrochloride (MK-2206 (2HCl)) is an orally active, BBB-penetrated allosteric AKT inhibitor with IC50s of 5 nM, 12 nM, and 65 nM for AKT1, AKT2, and AKT3, respectively. MK-2206 dihydrochloride induces autophagy[1][2].
(2S)-2-[[4-[(2-amino-4-oxo-7,8-dihydro-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,dihydrate
3-(2-(BENZYLOXY)-5-BROMOPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPAN-1-AMINE
BMS-536924
2,5-dibutoxy-4-(morpholino)benzenediazonium hexafluorophosphate
Letaxaban
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent
6-((7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yl)oxy)-N-methyl-1-naphthamide hydrochloride
N-[4-(1,3-benzothiazol-2-yl)phenyl]-2-[(4-tert-butylphenyl)sulfonylamino]acetamide
N-(3-Cyclopropyl(5,6,7,8,9,10-hexahydro-2-oxo-2H-cycloocta[B]pyran-3-YL)methyl)phenylbenzensulfonamide
N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide
(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)heptan-1-imine
2-[3-[2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-3-ium-4-yl]-2-methylbutan-2-yl]-4-methyl-5H-1,3-thiazole-4-carboxylate
2-[3-[2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-4-yl]-2-methylbutan-2-yl]-4-methyl-5H-1,3-thiazole-4-carboxylic acid
3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester
1-ethyl-2-[3-(1-ethylnaphtho[1,2-d][1,3]thiazol-2(1H)-ylidene)-2-methylprop-1-en-1-yl]naphtho[1,2-d][1,3]thiazol-1-ium
2-Furanyl-[4-[2-(2-methoxyphenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
(3R,3aS,7R,7aS)-3-[5-(1-benzothiophen-2-yl)-2-methoxyphenyl]-7-methyl-2-(phenylmethyl)-3a,6,7,7a-tetrahydro-3H-isoindol-1-one
3-Furanyl-[4-[2-(4-methoxyphenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
4-methoxy-N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide
3-Furanyl-[4-[2-(3-methoxyphenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
N-[2,5-diethoxy-4-[[(3-methoxyanilino)-sulfanylidenemethyl]amino]phenyl]-4-methylbenzamide
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[[4-(4-fluorophenyl)-5-[(1-methylpyrrol-2-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]acetamide
[4-[5-Tert-butyl-3-[(2-chlorophenyl)methyl]-7-triazolo[4,5-d]pyrimidinyl]-1-piperazinyl]-(2-furanyl)methanone
1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-[(dimethylamino)methyl]-N-[(E)-[2-[(4-fluorophenyl)methoxy]phenyl]methylideneamino]triazole-4-carboxamide
acetic acid [4-[[(3aS,4R,9aS,9bR)-2-(2-naphthalenyl)-1,3-dioxo-3a,4,9a,9b-tetrahydropyrrolo[1,2]pyrrolo[3,5-b]pyridazin-4-yl]-oxomethyl]phenyl] ester
2-[benzyl(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)amino]-N-[(E)-(4-methylphenyl)methylideneamino]acetamide
2-fluoro-N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-fluoro-N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-fluoro-N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-fluoro-N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-fluoro-N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-fluoro-N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-fluoro-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
(2S,3S,3aR,9bR)-N-[(2-chlorophenyl)methyl]-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
(1R,9S,10S,11S)-5-(2-fluorophenyl)-10-(hydroxymethyl)-N-(2-methoxyethyl)-12-methylsulfonyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-5-(2-fluorophenyl)-10-(hydroxymethyl)-N-(2-methoxyethyl)-12-methylsulfonyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
3-fluoro-N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-fluoro-N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-fluoro-N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-fluoro-N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-fluoro-N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-fluoro-N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-fluoro-N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-[4-[(1S,5R)-3-(2-fluorophenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
3-[4-[(1R,5S)-6-(2-fluorophenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
3-fluoro-N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
2-fluoro-N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-fluoro-N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-fluoro-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-fluoro-N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
(2R,3R,3aS,9bS)-N-[(2-chlorophenyl)methyl]-3-(hydroxymethyl)-7-(2-methoxyphenyl)-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
3-[4-[(1S,5R)-3-(2-fluorophenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
alpha-Kdo-(2->8)-alpha-Kdo-OAll(1-) II(1),I(7)-lactone
3-[2-benzylsulanyl-1,2-bis(4-methoxyphenyl)ethyl]-1H-indole
L-gamma-glutamyl-S-[(1E)-N-hydroxy-2-(1H-indol-3-yl)ethanimidoyl]-L-cysteinylglycine
Petunidin 3-glucoside
An anthocyanin cation that is petunidin substituted at position 3 by a beta-D-glucosyl residue
ARC 239 (dihydrochloride)
ARC 239 dihydrochloride is a selective α2B/2C adrenoceptor antagonist (pKd values are 5.95, 7.41 and 7.56 at α2A, α2B, and α2C receptors respectively). ARC 239 dihydrochloride binds to CHO cell membranes expressing human recombinant a2A-, a2B- or a2C-adrenoceptor subtypes with pKis of 5.6, 8.4, and 7.08, respectively[1].
HPPE
HPPE (compound 236) is a potential Bach1 inhibitor. Bach1 is a transcription factor of the cap'n'collar type alkaline region leucine zipper factor family (CNC-bZip) that regulates mitochondrial metabolism and reduces glucose utilization. HPPE can be used for research in psoriasis, multiple sclerosis, and COPD[1][2].